2-Day Virtual Seminar

Verification and Validation - Product, Equipment/Process, Software and QMS : 2-Day Virtual Seminar

BY: John E Lincoln, Principal, J. E. Lincoln and Associates

Virtual Training Through WebEx

Simu Live
(On-demand Streaming - Virtual Training Through WebEx)
  • Course Description
  • Agenda
  • Speaker
  • Price/Register

Topic Background:

Both the U.S. FDA and EU's MDR expect documented risk-based V&V under U.S. FDA cGMPs, the EU MDR, ICH Q9 and ISO 14971

Why should you attend:

FDA Warning Letters and recent high-profile recalls indicate major cGMP deficiencies in verification and validations. And now the FDA is taking an even tougher stance. One major failing is lack of sufficient or targeted risk-based V&V planning / execution. Consider some basic principles in the FDA's various guidance documents on Validation. A software V&V "model" will be presented. The "must have" elements from ISO 14971( and ICH Q9) for hazard analysis and product / process risk management. Integration of validation essentials into a company's quality management system.

Description:

Review a company's Verification and Validation system for major cGMP deficiencies. Address the FDA's newer and tougher regulatory stance, and it's most recent Process Validation guidance upgrade (device principles from pharma). One major failing is lack of sufficient or targeted risk-based V&V planning and associated documentation. Starting with a Master Validation Plan, evaluating its elements against ISO 14971 and ICH Q9 for hazard analysis and product risk management, allows the development of meaningful product quality-specific process validations. Consider Human Factors / Use Engineering elements where required. Also the roles of different V&V protocols; how to employ equipment / process DQs, IQs, OQs, and PQs, or their equivalents. Our matrix examples simplify "as-product", in-product, equipment and process software, assuring key FDA requirements are not overlooked. The QSR/QMRS/ISO 13485 and 21 CFR Part 11 and cybersecurity are all considered.


Areas Covered:

Participants will learn how an effective validation system is a critical requirement to the movement toward a risk-based approach to compliance and product safety. Also to be discussed is how to tackle process validation for medical device combination products.

Issues to be covered include:

  • Assurance of product quality from CGMP compliant validation
  • Prospective, Concurrent, or Retrospective Validations
  • Learn how to improve process system knowledge and understanding
  • Learn methods for developing validations and best practices
  • Understand the scope of regulations governing validation and identify gaps
  • Develop a plan to rectify existing validation plans, protocols and reports; the use of "working definitions"
  • Learn about Product, Process, Production / Test Equipment V&V
  • Learn how to construct, implement and deploy a Validation Master Plan
  • Compile a Compliant V&V Test Report with Various Test Cases
Who will Benefit:

This webinar will provide valuable assistance to all regulated companies that need to review and modify their Process Validation Planning and Execution / Documentation. While this information is focused on Medical Devices, its principles apply to personnel / companies in the Pharmaceutical, Diagnostic, and Biologics fields. The employees who will benefit include:

  • Senior management
  • Regulatory Affairs
  • Quality Assurance
  • Production
  • Engineering, indluding Software
  • All personnel involved in verification and/or validation planning, execution and documentation.
Day 01(10:00 AM ET – 4:00 PM ET)
  • 08:00 AM MT Introduction (personal / course information)
  • 09:05 AM Session 1 – Master V& V Planning (~83 slides)
    • V&V; “Working” Definitions
    • Key Areas in Product Validation
    • Key Equipment, Process, Software and QMS V&V Activities
    • Requirements – The Basics
    • DQ, IQ, OQ, PQs or Equivalents
    • Protocols / Test Cases; Examples; Proving (V&V) the Requirements
    • Master Validation Plans; Life Cycles; Regulatory “Hot Buttons”
  • 10:20 AM Break / Q&A
  • 11:30 AM Session 2 – Process Validation ~(63 slides)
    • Definitions
    • Process V&V FDA Guidance
    • Process V&V activities
  • 12:20 PM Lunch Break
  • 12:40 PM Session 3 – Data Integrity (~61 slides)
    • Elements of Data Integrity
    • True copies
    • Archived documentation
  • 01:20 PM Project Management (~58 slides)
    • Project Management
    • Gantt
    • CPM
    • PERT
  • 01:50 PM Review Day 1; Q&A
  • 02:00 PM End, Day 1
  • Note: Timings are approximate
Day 02(10:00 AM ET – 4:00 PM ET)
  • 08:00 AM MT Review of Day 1
  • 08:10 AM Session 5 – Software / Firmware V&V (~67 slides)
    • Documentation – The 10 Elements
    • V&V “Models” – For the 4 Types of SW Validations
    • 21 CFR Part 11, “Electronic Records / Signatures”
    • Legacy, Hybrid, New and ER / ES Systems
    • Life Cycle and “Cloud” Considerations
    • Types of Testing; “Typical” Test Report and Test Case Samples
    • GAMP® 4 & 5; IEC 62304
  • 09:25 AM Break / Q&A
  • 09:35 AM Session 6 – Product Risk Management (~41 slides)
    • Patient Hazard / Risk Management per ISO 14971:2019
    • QMS / System Level
    • File / Review (Benefit / Risk)
    • Narrative / Descriptive Information
    • Hazards
    • FTA
    • D-, P-, U-FME[C]A + Normal
  • 10:35 AM Session 7 -- Human Factors / Use Engineering (~41 slides)
    • FDA and EU Requirements
    • IEC 62366-1, -2
    • The 9 Stage Process + Additional Human Factors Specifics
    • The UE File
  • 11:35 AM Lunch Break
  • 11:55 AM Session 8 -- GDP (18 slides)
    • Basic Good Documentation Practices
  • 12:25 PM Session 9 – Cybersecurity (77 slides)
    • Cybersecurity
  • 01:45 PM Review Days 1 and 2; Q&A
  • 02:00 PM End, Day 2
John E Lincoln
John E Lincoln Principal, J. E. Lincoln and Associates

John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 42 years’ experience in U.S. FDA-regulated industries, 28 as a full-time consultant. John has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He's held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D). In addition, John has prior experience in military, government, electronics, and aerospace. He has published numerous articles in peer reviewed journals, conducted workshops and webinars worldwide on CAPA, 510(k)s, risk analysis / management, FDA / GMP audits, validation, root cause analysis, and others. John is a graduate of UCLA.

Register Now

Online using Credit card

$1,099.00

(One Dial-in One Attendee)

(After registration, we will video stream the training
on your convenient dates)

$6,499.00

Group-Max. 10 Attendees

(After registration, we will video stream the training
on your convenient dates)

For discounts on multiple registrations, contact customer care at +1-888-771-6965.

Other Registration Options

By order form / PO#

Payment Modes

By Check -

To pay by check please contact customercare@fdatrainingalert.com

By Wire -

Register / Pay by Wire TransferPlease contact us at +1-888-771-6965 to get details of wire transfer option.

Terms & Conditions to Register for the Seminar/Conference/Event »

Terms & Conditions to register for the Seminar/Conference/Event

Your Registration for the seminar is subject to following terms and conditions. If you need any clarification before registering for this seminar please call us @ +1-888-771-6965 or email us @ customercare@fdatrainingalert.com

Payment:
Payment is required before 2 days of the date of the conference. We accept American Express, Visa and MasterCard. Make checks payable to MetricStream Inc. ( our parent company)

Cancellations and Substitutions:
Written cancellations through fax or email (from the person who has registered for this conference) received at least 10 calendar days prior to the start date of the event will receive a refund — less a $300 administration fee. No cancellations will be accepted — nor refunds issued — within 10 calendar days from the start date of the event.

On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($300) will be transferred to any future FDATrainingAlert event and a credit note will be issued.

Substitutions may be made at any time. No-shows will be charged the full amount.

We discourage onsite registrations, however if you wish to register onsite payment to happen through credit card immediately or check to be submitted onsite. Conference material will be given on the spot if it is available after distributing to other attendees. In case it is not available we will send the material after the conference is over.

In the event FDATrainingAlert cancels the seminar, FDATrainingAlert is not responsible for any airfare, hotel, other costs or losses incurred by registrants. Some topics and speakers may be subject to change without notice.

Attendance confirmation and Documents to carry to the seminar venue:
After we receive the payment from the registered attendee an electronic event pass will be sent to the email address associated with the registrant before 5 working days from the seminar date. Please bring the pass to the venue of the event.

Conference photograph / video:
By registering and attending FDATrainingAlert conference you agree to have your photographs or videos taken at the conference venue and you do not have any objections to use these photos and videos by FDATrainingAlert for marketing, archiving or any other conference related activities. You agree to release FDATrainingAlert for any kind of claims arising out of copyright or privacy violations.

You Recently Viewed